Serum soluble CD26/DPP4 titer variation is a potential prognostic biomarker in cancer therapy with a humanized anti-CD26 antibody.

Biomark Res · 2021 · PMC7989014 · PMID 33757558

Europe PMC DOI

hedged sentences

0.0650

closest p · 1.3× alpha

0.0650

boldest claim

The sentences

almost reached statistical significancep = 0.065so close (0.05 < p ≤ 0.1)

In 19 MM cases, statistically significant correlation between variation in pre/post day 29 serum DPP4 titer and tumor volume was observed by SRDC analysis, while the correlation between day 29pre serum sCD26 titer and tumor volume almost reached statistical significance ( p = 0.065) by PPMC analysis.

also in 378 other papers

tendency toward significanceno p-value reported

For Column Q2W (17 or 18 cases), Q2W, males (14 cases), MM (17 or 18 cases), MM, Q2W (11 or 12 cases), and MM, Q2W, males (9 cases), the Indexes of each column for the Outcomes were determined to have statistical significance or tendency toward significance.

also in 340 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.